Synthetic variants of the rabies virus glycoprotein g for the generation of pseudotyped baculoviruses and their use in anti-rabies vaccine formulations

CO20260008938A2Pending Publication Date: 2026-06-30FARMACOLOGICOS VETERINARIOS S A C

Patent Information

Authority / Receiving Office
CO · CO
Patent Type
Applications
Current Assignee / Owner
FARMACOLOGICOS VETERINARIOS S A C
Filing Date
2026-06-17
Publication Date
2026-06-30
Patent Text Reader

Abstract

The present invention relates to synthetic designs or chimeric proteins for pseudotyping baculovirus (Autographa californica nuclear polyhedrosis virus) with the rabies virus glycoprotein G (gG) on its surface (Bac::gG-FL), which can be used in rabies vaccine formulations. The chimeric protein is designed from a gene cassette containing genetic fragments from the ectodomain of the Pasteur variant rabies virus glycoprotein G, a 7-amino-acid connector sequence (GGGGSGG), as well as transmembrane (TM) and cytoplasmic (CT) regions of the baculoviral protein gp64, the arrangement of which in the designed gene cassette is shown in Figure 1.
Need to check novelty before this filing date? Find Prior Art